ナミキ商事株式会社 医薬品及び創薬化学品の専門商社

医薬品及び創薬化学品の専門商社

検索検索

バイオ製品Bio Products

タンパク質、抗体、アッセイキット

タンパク質カタログ

輸入に関する法規制チェックは、御見積のご依頼をいただいた際に行います。
法規制によっては、定価として記載の価格に追加の費用が発生する場合や供給出来ない場合がございますので、あらかじめご了承ください。

サプライヤー
AcroBioSystems
カタログNo.
CLM-H82Q3
製品名称
Biotinylated Human CLEC4M Protein, Avitag?,His Tag (MALS verified)
タンパク質名
CLEC4M
Species
Human
HOST
HEK293
25ug: 101,900円
お問い合わせ
200ug: 404,500円
お問い合わせ

Overview

Synonyms -
Characteristics This protein carries an Avi tag (Avitag?) at the N-terminus, followed by a polyhistidine tag. The protein has a calculated MW of 41.3 kDa. The protein migrates as 42-45 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.
Endotoxin Level N/A
Purity 95%
Description CLEC4M encodes a C-type lectin receptor crucially involved in cell adhesion and diverse pathogen recognition. This receptor notably binds a wide array of evolutionarily divergent and clinically significant pathogens, including Mycobacterium tuberculosis, as well as viruses such as Ebola, Hepatitis C (HCV), HIV-1, Influenza A, West Nile virus, and the SARS-CoV acute respiratory syndrome coronavirus. Structurally, the protein is organized into four distinct domains: an N-terminal cytoplasmic domain implicated in internalization, a transmembrane region, a flexible tandem-repeat neck domain of variable length, and a C-terminal carbohydrate recognition domain (CRD). CLEC4M shares close sequence and functional homology with the neighboring gene CD209 (DC-SIGN), though they differ in specific viral recognition profiles and tissue expression patterns. CLEC4M exhibits high expression in the endothelial cells of the liver, lymph node, and placenta, and crucially, polymorphisms within its tandem-repeat neck domain have been associated with resistance to SARS infection.
Reference -
URL https://www.acrobiosystems.com/products/protein/clec4m-human-clm-h82q3

お問い合わせリスト(-)

お問い合わせフォーム